Abiological drugs register for systemic lupus erythematosus (SLE) has provided important...

Paul Mulholland speaks to President of the Irish Society for Rheumatology Prof Geraldine McCarthy

Pain is an important consideration for people with rheumatic and musculoskeletal diseases (RMDs)...

Many different agents are available to treat people with axSpA, but they do not always work...

An increased risk of adverse pregnancy and neonatal outcomes has been reported for pregnancies...

Three abstracts presented at the 2022 EULAR Congress shed new light on risk of a wide...

The British Society for Rheumatology (BSR) has launched a new guideline for the treatment of psoriatic...

Results presented at the 2022 EULAR Congress show that early achievement of minimal...

Lupus nephritis (LN) is a frequent complication of systemic lupus erythematosus (SLE), and one...

The prevalence of comorbidities in axial spondyloarthritis (AxSpA) populations is high...

Irish rheumatologists are struggling to access two recently-approved biological drugs to treat lupus...

Working with multidisciplinary teams (MDTs) and keeping an open mind is important in managing both interstitial...